FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520041047> ?p ?o ?g. }

• W1520041047 endingPage "291" @default.
• W1520041047 startingPage "283" @default.
• W1520041047 abstract "We performed a 1-year study to determine whether intermittent short courses of the microemulsion formulation of cyclosporin (Neoral) could effectively control plaque psoriasis and whether tapering or abrupt cessation of cyclosporin therapy would influence time to relapse. Four hundred patients with plaque psoriasis were included in this open, multicentre, randomized study. All patients commenced cyclosporin at a dose of 2.5 mg/kg daily. Cyclosporin dosage could be increased to a maximum of 5 mg/kg daily. Treatment was continued until clearance of psoriasis or for a maximum of 12 weeks. Patients were then randomly assigned either to stop cyclosporin abruptly or to have the dose reduced by 1 mg/kg daily each week until cessation. On relapse, patients were given another course of cyclosporin. Patients were followed for at least 1 year, during which they could receive as many treatment courses as necessary. The number of patients who required one, two, three and four treatment courses was 400, 259, 117 and 26, respectively. The median time to relapse after the end of the first treatment period was 109 days in the group of patients randomized to stop cyclosporin abruptly and 113 days in patients randomized to taper off cyclosporin (P = 0.038). More than 30% of patients had not relapsed 6 months after having stopped treatment. After each treatment course, the Kaplan-Meier probability of achieving 75% or more reduction in disease area by day 84 of treatment was 83%, 76%, 73% and 66%, respectively. Mean serum creatinine concentration and blood pressure did not show any clinically significant changes over time. Our results show that intermittent short-course therapy with Neoral, when used in conjunction with topical therapy, is well tolerated and provides effective control of plaque psoriasis for 1 year. Tapering off cyclosporin on treatment cessation induces a slight delay in psoriasis relapse." @default.
• W1520041047 created "2016-06-24" @default.
• W1520041047 creator A5016898527 @default.
• W1520041047 creator A5020129995 @default.
• W1520041047 creator A5030540110 @default.
• W1520041047 creator A5031706613 @default.
• W1520041047 creator A5034766747 @default.
• W1520041047 creator A5063584037 @default.
• W1520041047 creator A5068573206 @default.
• W1520041047 creator A5071880182 @default.
• W1520041047 creator A5073304823 @default.
• W1520041047 creator A5075632567 @default.
• W1520041047 creator A5078496716 @default.
• W1520041047 creator A5078821076 @default.
• W1520041047 date "1999-08-01" @default.
• W1520041047 modified "2023-10-17" @default.
• W1520041047 title "Intermittent short courses of cyclosporin (Neoral®) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study" @default.
• W1520041047 cites W1969186806 @default.
• W1520041047 cites W1973443311 @default.
• W1520041047 cites W1982197356 @default.
• W1520041047 cites W2000906647 @default.
• W1520041047 cites W2009653423 @default.
• W1520041047 cites W2015994420 @default.
• W1520041047 cites W2019276276 @default.
• W1520041047 cites W2019320114 @default.
• W1520041047 cites W2049933047 @default.
• W1520041047 cites W2067327580 @default.
• W1520041047 cites W2086848741 @default.
• W1520041047 cites W2097200436 @default.
• W1520041047 cites W2107722406 @default.
• W1520041047 cites W2128761736 @default.
• W1520041047 cites W2142625039 @default.
• W1520041047 cites W2324161037 @default.
• W1520041047 cites W2338260086 @default.
• W1520041047 cites W4231344278 @default.
• W1520041047 cites W4233438854 @default.
• W1520041047 cites W4235842035 @default.
• W1520041047 cites W4243306660 @default.
• W1520041047 cites W4322697958 @default.
• W1520041047 doi "https://doi.org/10.1046/j.1365-2133.1999.02977.x" @default.
• W1520041047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10468801" @default.
• W1520041047 hasPublicationYear "1999" @default.
• W1520041047 type Work @default.
• W1520041047 sameAs 1520041047 @default.
• W1520041047 citedByCount "128" @default.
• W1520041047 countsByYear W15200410472012 @default.
• W1520041047 countsByYear W15200410472013 @default.
• W1520041047 countsByYear W15200410472014 @default.
• W1520041047 countsByYear W15200410472015 @default.
• W1520041047 countsByYear W15200410472016 @default.
• W1520041047 countsByYear W15200410472017 @default.
• W1520041047 countsByYear W15200410472018 @default.
• W1520041047 countsByYear W15200410472019 @default.
• W1520041047 countsByYear W15200410472020 @default.
• W1520041047 countsByYear W15200410472021 @default.
• W1520041047 countsByYear W15200410472022 @default.
• W1520041047 countsByYear W15200410472023 @default.
• W1520041047 crossrefType "journal-article" @default.
• W1520041047 hasAuthorship W1520041047A5016898527 @default.
• W1520041047 hasAuthorship W1520041047A5020129995 @default.
• W1520041047 hasAuthorship W1520041047A5030540110 @default.
• W1520041047 hasAuthorship W1520041047A5031706613 @default.
• W1520041047 hasAuthorship W1520041047A5034766747 @default.
• W1520041047 hasAuthorship W1520041047A5063584037 @default.
• W1520041047 hasAuthorship W1520041047A5068573206 @default.
• W1520041047 hasAuthorship W1520041047A5071880182 @default.
• W1520041047 hasAuthorship W1520041047A5073304823 @default.
• W1520041047 hasAuthorship W1520041047A5075632567 @default.
• W1520041047 hasAuthorship W1520041047A5078496716 @default.
• W1520041047 hasAuthorship W1520041047A5078821076 @default.
• W1520041047 hasConcept C126322002 @default.
• W1520041047 hasConcept C141071460 @default.
• W1520041047 hasConcept C16005928 @default.
• W1520041047 hasConcept C168563851 @default.
• W1520041047 hasConcept C204243189 @default.
• W1520041047 hasConcept C2776694085 @default.
• W1520041047 hasConcept C2779528694 @default.
• W1520041047 hasConcept C2780564577 @default.
• W1520041047 hasConcept C42219234 @default.
• W1520041047 hasConcept C71924100 @default.
• W1520041047 hasConceptScore W1520041047C126322002 @default.
• W1520041047 hasConceptScore W1520041047C141071460 @default.
• W1520041047 hasConceptScore W1520041047C16005928 @default.
• W1520041047 hasConceptScore W1520041047C168563851 @default.
• W1520041047 hasConceptScore W1520041047C204243189 @default.
• W1520041047 hasConceptScore W1520041047C2776694085 @default.
• W1520041047 hasConceptScore W1520041047C2779528694 @default.
• W1520041047 hasConceptScore W1520041047C2780564577 @default.
• W1520041047 hasConceptScore W1520041047C42219234 @default.
• W1520041047 hasConceptScore W1520041047C71924100 @default.
• W1520041047 hasIssue "2" @default.
• W1520041047 hasLocation W15200410471 @default.
• W1520041047 hasLocation W15200410472 @default.
• W1520041047 hasOpenAccess W1520041047 @default.
• W1520041047 hasPrimaryLocation W15200410471 @default.
• W1520041047 hasRelatedWork W1988356095 @default.
• W1520041047 hasRelatedWork W1999967090 @default.
• W1520041047 hasRelatedWork W2041828149 @default.

• next